# Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer

> **NCT02141919** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 16 (actual)

## Conditions studied

- Renal Cancers

## Interventions

- **RADIATION:** Stereotactic Ablative Radiation Therapy

## Key facts

- **NCT ID:** NCT02141919
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-06
- **Primary completion:** 2026-05
- **Final completion:** 2026-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02141919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02141919, "Stereotactic Ablative Body Radiation Therapy for Patients With Primary Renal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02141919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*